PBF.CN Planet Based Foods CNQ -81.82% to C$0.01 (11 Feb 2026): Watch liquidity

PBF.CN stock plunged to C$0.01 during market hours on 11 Feb 2026, down 81.82% on heavy trade as sellers overwhelmed thin liquidity. Volume hit 35,000 shares vs average 3,347 shares, signalling outsized intraday flow. We summarise why the drop matters, the company metrics behind it, and what traders should watch next.

PBF.CN stock: Intraday move, volume and immediate drivers

Planet Based Foods Global Inc. (PBF.CN) opened at C$0.05 and closed the session at C$0.01, a -81.82% change from the previous close of C$0.055. Trading volume of 35,000.00 was about 10.46x the average volume, showing forced selling into very low liquidity.

There were no material company press releases in the provided feed tied to the move. The sharp fall aligns with microcap volatility where order imbalances and low float can produce outsized price swings during market hours on the CNQ exchange.

PBF.CN stock: Fundamentals and valuation snapshot

At C$0.01, PBF.CN shows EPS C$0.03 and a quoted PE of 0.33, but those ratios are distorted at penny prices and by negative book value. Market capitalisation stands at C$182,850.00 with 18,285,000.00 shares outstanding.

Price averages are weak: 50-day C$0.07 and 200-day C$0.08. Year high is C$0.27 and year low is C$0.01, underscoring the stock’s long decline and valuation stress relative to Healthcare peers.

PBF.CN stock: Technicals and short-term trading signals

Momentum indicators show oversold conditions but mixed strength: RSI 38.62, MACD -0.01 and ADX 38.04 indicating a strong trending move. Bollinger bands sit at Upper C$0.12, Middle C$0.08, Lower C$0.04, so price is below the lower band on the session fall.

Volume-based measures warn of distribution: OBV is -164,156.00 and MFI 26.68, both consistent with selling pressure. Short-term traders should note extremely wide spreads and high ATR C$0.01, reflecting execution risk on CNQ.

Meyka AI rates PBF.CN with a score out of 100 and analyst context

Meyka AI rates PBF.CN with a score out of 100. The proprietary Meyka score is 65.85 / 100, grade B with a suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus.

Independent company rating dated 06 Feb 2026 shows a C+ and a Sell recommendation, driven by weak DCF and leverage metrics. Investors should weigh both the Meyka composite and third-party score when forming views.

PBF.CN stock: Forecasts and price targets from Meyka AI

Meyka AI’s forecast model projects a quarterly price of C$0.05 and a 12-month projection of C$0.01774863. Versus the current C$0.01, the quarterly projection implies +400.00% upside and the 12-month projection implies +77.49% upside. Forecasts are model-based projections and not guarantees.

Given trading dynamics, we set near-term technical resistance at C$0.05 and a conservative 12-month target of C$0.02 while a long-term scenario driven by recovery in demand and liquidity could push toward C$0.18 over several years. These targets carry high uncertainty.

PBF.CN stock: Risks, liquidity and sector comparison

Key risks are acute liquidity, low market cap, negative working capital metrics and high receivables/payables distortions. Current ratio is 0.06, and enterprise value to EBITDA metrics are unreliable given negative operating cash flow per share -0.01712.

Healthcare sector context shows underperformance versus broader market; investors should compare PBF.CN to drug manufacturers and packaged foods peers, and monitor for any issuer updates. For a live view check our Meyka page for PBF.CN data and alerts.

Final Thoughts

PBF.CN stock’s collapse to C$0.01 on 11 Feb 2026 is primarily a liquidity-driven move amplified by a low float and outsized intraday selling. Fundamentals show very small market cap (C$182,850.00), EPS C$0.03, and distorted ratios that make headline PE figures unreliable. Meyka AI’s composite score is 65.85 / 100 (Grade B, HOLD), while an independent rating on 06 Feb 2026 was C+ / Sell, reflecting different risk weightings. Meyka AI’s forecast model projects C$0.05 quarterly (implied +400.00%) and C$0.01774863 in 12 months (implied +77.49%). These projections assume improved liquidity and no further dilution; they are model-based and not guarantees. For traders, the immediate priority is liquidity management: expect wide spreads, execution risk, and the potential for further downside if selling persists. Long-term recovery scenarios exist but require demonstrable revenue growth, tighter working capital, and improved market-making on CNQ. Use the data here as market analysis, not investment advice.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.